Get started
Author

Catherine Vergely

Observed names: C V Vergely, C Vergely, C. Vergely, C. Vergely-Vandriess, C. Vergely-Vandriesse, C. Vergely-Vanriessen, C., Vergely, CV Vergely, Catherine VERGELY, Catherine Vergely A, Catherine Vergely-Vandriesse, Pr Catherine Vergely, VERGELY-VANDRIESSE, Catherine, Vergely, Catherine, Vergely-Vandriesse, C.
Observed institutions: Lyon 1 Université, Inserm, Université de Bourgogne, Centre Georges François Leclerc, CHU Dijon Bourgogne, Université Bourgogne Franche-Comté, Centre de recherche Translationnelle en Médecine moléculaire, Physiopathologie et Epidémiologie Cérébro-Cardiovasculaires, Université Bourgogne Europe
ORCID: 0000-0003-4009-776X
Observed ORCID: 0000-0003-4009-776X
OpenAlex ID: A5074647755
Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis
2022 · Luc Rochette, Geoffrey Dogon, et al. · International Journal of Molecular Sciences · 921
PDF
Diabetes, oxidative stress and therapeutic strategies
2014 · Luc Rochette, Marianne Zeller, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 530
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?
2013 · Luc Rochette, Julie Lorin, et al. · Pharmacology & Therapeutics · 456
Direct and indirect antioxidant properties of α‐lipoic acid and therapeutic potential
2013 · Luc Rochette, Stéliana Ghibu, et al. · Molecular Nutrition & Food Research · 297
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
2015 · Luc Rochette, Charles Guenancia, et al. · Trends in Pharmacological Sciences · 248
PDF
Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes
2015 · Luc Rochette, Steliana Ghibu, et al. · Canadian Journal of Physiology and Pharmacology · 240
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
2016 · Charles Guenancia, Annick Lefebvre, et al. · Journal of Clinical Oncology · 210
PDF
Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets
2020 · Luc Rochette, Marianne Zeller, et al. · Trends in Endocrinology and Metabolism · 175
PDF
Antioxidant Properties of an Endogenous Thiol: Alpha-lipoic Acid, Useful in the Prevention of Cardiovascular Diseases
2009 · Stéliana Ghibu, Carole Richard, et al. · Journal of Cardiovascular Pharmacology · 160
GDF15 and Cardiac Cells: Current Concepts and New Insights
2021 · Luc Rochette, Geoffrey Dogon, et al. · International Journal of Molecular Sciences · 151
PDF
The Role of Osteoprotegerin and Its Ligands in Vascular Function
2019 · Luc Rochette, Alexandre Meloux, et al. · International Journal of Molecular Sciences · 150
PDF
Carbon monoxide: Mechanisms of action and potential clinical implications
2012 · Luc Rochette, Yves Cottin, et al. · Pharmacology & Therapeutics · 145
Postnatal Overfeeding in Rodents by Litter Size Reduction Induces Major Short- and Long-Term Pathophysiological Consequences
2013 · Ahmed Habbout, Na Li, et al. · Journal of Nutrition · 138
PDF
Systemic Free Radical Activation Is a Major Event Involved In Myocardial Oxidative Stress Related to Cardiopulmonary Bypass
2002 · Gaëlle Clermont, Catherine Vergely, et al. · Anesthesiology · 134
PDF
Studies by electron paramagnetic resonance of the importance of iron in the hydroxyl scavenging properties of ascorbic acid in plasma: Effects of iron chelators
1998 · M Benderitter, V Maupoil, et al. · Fundamental and Clinical Pharmacology · 133
Arginine and nitric oxide synthase: Regulatory mechanisms and cardiovascular aspects
2013 · Julie Lorin, Marianne Zeller, et al. · Molecular Nutrition & Food Research · 122
Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction
2014 · Jérôme Lugrin, Roumen Parapanov, et al. · The Journal of Immunology · 115
PDF
Antioxidative Properties of Pyruvate and Protection of the Ischemic Rat Heart During Cardioplegia
1999 · Petr Dobsak, Carol Courderot-Masuyer, et al. · Journal of Cardiovascular Pharmacology · 110
Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes
2017 · Luc Rochette, Marianne Zeller, et al. · Trends in Endocrinology and Metabolism · 103
The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
2017 · Luc Rochette, Alexandre Meloux, et al. · Pharmacology & Therapeutics · 103
NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging
2006 · Alexandra Oudot, Caroline Martin, et al. · Free Radical Biology and Medicine · 103
The iron-regulatory hormone hepcidin: A possible therapeutic target?
2014 · Luc Rochette, Aurélie Gudjoncik, et al. · Pharmacology & Therapeutics · 98
Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure
2005 · Virginie Mellin, Marc Isabelle, et al. · European Heart Journal · 90
PDF
Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
2020 · Luc Rochette, Alexandre Meloux, et al. · Molecules · 84
PDF
Iron, oxidative stress, and redox signaling in the cardiovascular system
2014 · Aurélie Gudjoncik, Charles Guenancia, et al. · Molecular Nutrition & Food Research · 84
Works count: 329
Citation count: 8,805
H-index: 47
I10-index: 136
Year
Topic
Type